Brown Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
43,951
-40,417
-48% -$1.92M 0.39% 50
2026
Q1
$4.35M Sell
84,368
-35,567
-30% -$2.49M 0.62% 41
2025
Q4
$11.1M Sell
119,935
-158,105
-57% -$15.1M 0.91% 33
2025
Q3
$20.6M Sell
278,040
-89,401
-24% -$9.05M 0.85% 36
2025
Q2
$47.7M Buy
367,441
+15,101
+4% +$2.19M 1.39% 30
2025
Q1
$56.1M Buy
352,340
+47,560
+16% +$8.6M 1.69% 23
2024
Q4
$56.5M Sell
304,780
-45,681
-13% -$8.87M 1.31% 28
2024
Q3
$74M Sell
350,461
-57,386
-14% -$9.97M 1.59% 22
2024
Q2
$54.6M Buy
407,847
+329,448
+420% +$62.3M 1.1% 28
2024
Q1
$16.8M Buy
+78,399
New +$15.4M 0.3% 46

Other funds holding INSP

Brown Capital Management's INSP Position: Q2 2026 in Review

Brown Capital Management reduced its Inspire Medical Systems (INSP) stake by 48% in Q2 2026, selling an estimated $1.92M and leaving 43,951 shares worth $1.96M. The position accounts for 0.39% of the portfolio, ranked #50.

Brown Capital Management first reported a position in INSP in Q1 2024 and has held it in 10 quarters since. The position peaked at $74M in Q3 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Brown Capital Management held 43,951 shares of Inspire Medical Systems worth $1.96M as of Q2 2026.
  • Brown Capital Management sold 40,417 Inspire Medical Systems shares in Q2 2026, an estimated $1.92M.
  • Inspire Medical Systems made up 0.39% of Brown Capital Management's portfolio in Q2 2026, its #50 holding.
  • Brown Capital Management first reported a position in Inspire Medical Systems in Q1 2024 and has held it in 10 quarters since.
  • Brown Capital Management's Inspire Medical Systems position peaked at $74M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Brown Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.